Study Stopped
Unable to enroll enough participants
Cold Saline Irrigation Before Endobronchial Biopsy
Evaluating the Use of Preventive Cold Saline to Decrease Bleeding Associated With Endobronchial Biopsy
1 other identifier
interventional
6
1 country
1
Brief Summary
Patients undergoing an endobronchial ultrasound and biopsy can experience bleeding during the biopsy. These biopsies are read in real time by pathologists who travel to the endoscopy unit during the procedure. Often, when this happens, the blood contaminates the pathology slides making the slide unreadable. This then requires more biopsies to be performed, thus prolonging the procedure, and increasing anesthesia time. One innovative way to reduce bleeding may be to irrigate the bronchial wall with cold saline, where the biopsy is to be taken, immediately before biopsy, thus causing vasoconstriction and possibly resulting in less blood contamination on the biopsy slides. The current study will evaluate this prophylactic irrigation with saline to control bleeding, thus resulting in a quicker diagnostic result of the biopsies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 3, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedFirst Posted
Study publicly available on registry
April 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedResults Posted
Study results publicly available
April 2, 2026
CompletedApril 2, 2026
March 1, 2026
1.5 years
August 3, 2023
February 12, 2026
March 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Unreadable Biopsy Slides
cumulative number of unreadable slides across all biopsy slides noted by the pathologist to be unreadable due to blood on slide
from enrollment until discharge from biopsy appointment, up to 12 hours
Study Arms (2)
Flush Group
EXPERIMENTALAfter identifying the lymph node or lesion to be biopsied on ultrasound, using the endobronchial ultrasound scope, two 60mL syringes of cold saline will be inserted, through the biopsy channel of the endobronchial ultrasound scope, directly onto the bronchial wall where the biopsies are to be performed. The saline will then be sucked out of the airway using the endobronchial ultrasound scope.
Standard Care Group
NO INTERVENTIONNo irrigation before the biopsy
Interventions
After identifying the lymph node or lesion to be biopsied on ultrasound, using the endobronchial ultrasound scope, two 60mL syringes of cold saline will be inserted, through the biopsy channel of the endobronchial ultrasound scope, directly onto the bronchial wall where the biopsies are to be performed. The saline will then be sucked out of the airway using the endobronchial ultrasound scope.
Eligibility Criteria
You may qualify if:
- Undergoing an endobronchial ultrasound and biopsy at Bethesda North Hospital
You may not qualify if:
- Under 18 years old
- Does not speak English
- Unable to consent to involvement in the research study
- Is pregnant
- Has a bleeding disorder/diagnosis
- Currently taking anticoagulant medications and not stopped for procedure
- Documented low platelets (\<100,000)
- Had a biopsy taken immediately prior to the endobronchial ultrasound
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TriHealth Inc.lead
Study Sites (1)
Bethesda North Hospital
Cincinnati, Ohio, 45242, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Nurse Researcher
- Organization
- TriHealth
Study Officials
- PRINCIPAL INVESTIGATOR
Austin Pittman, BSN, RN
TriHealth Inc.
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2023
First Posted
April 18, 2024
Study Start
December 1, 2023
Primary Completion
May 23, 2025
Study Completion
December 30, 2025
Last Updated
April 2, 2026
Results First Posted
April 2, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share